Wnt3a stimulates Mepe, Matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2287-2296

  Cho, Young Dan ^a   Kim, Woo Jin ^a   Yoon, Won Joon ^a   Woo, Kyung Mi ^a   Baek, Jeong Hwa ^a   Lee, Gene ^a   Kim, Gwan Shik ^a   Ryoo, Hyun Mo ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; DICKKOPF 1 PROTEIN; LYMPHOID ENHANCER FACTOR 1; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MESSENGER RNA; NOGGIN; SMALL INTERFERING RNA; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; AUTOCRINE EFFECT; BONE DEVELOPMENT; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; WNT SIGNALING PATHWAY;

3T3 CELLS; ANIMALS; AUTOCRINE COMMUNICATION; BASE SEQUENCE; BETA CATENIN; BINDING SITES; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CARRIER PROTEINS; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR MATRIX PROTEINS; GENES, REPORTER; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MOLECULAR SEQUENCE DATA; MYOBLASTS; OSTEOGENESIS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; SMAD1 PROTEIN; SMAD5 PROTEIN; TIME FACTORS; TRANSFECTION; UP-REGULATION; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84857467271     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24038     Document Type: Article

References (55)

1. Bienz M. 1998. TCF: Transcriptional activator or repressor? Curr Opin Cell Biol 10: 366-372.
2. Billin AN, Thirlwell H, Ayer DE. 2000. Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 20: 6882-6890.
3. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521.
4. Caverzasio J, Manen D. 2007. Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology 148: 5323-5330.
5. Chen AE, Ginty DD, Fan CM. 2005. Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433: 317-322.
6. Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC, Alman BA. 2007. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 282: 526-533.
7. Cho YD, Yoon WJ, Woo KM, Baek JH, Lee G, Cho JY, Ryoo HM. 2009. Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2. J Biol Chem 284: 25230-25240.
8. Clement-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G. 2005. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102: 17406-17411.
9. De Boer J, Wang HJ, Van Blitterswijk C. 2004. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10: 393-401.
10. Fischer L, Boland G, Tuan RS. 2002. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277: 30870-30878.
11. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
12. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA. 2003. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278: 1998-2007.
13. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8: 727-738.
14. Hill TP, Taketo MM, Birchmeier W, Hartmann C. 2006. Multiple roles of mesenchymal beta-catenin during murine limb patterning. Development (Cambridge, England) 133: 1219-1229.
15. Intini G, Capelo L, Cox K, Rosen V. Increasing canonical Wnt signaling does not rescue the fracture phenotype of mice lacking Bmp2. ASBMR annual meeting abstract MO0200.
16. Johnson ML, Kamel MA. 2007. The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19: 376-382.
17. Kahler RA, Westendorf JJ. 2003. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278: 11937-11944.
18. Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, Kronenberg HM, Mishina Y. 2009. Wnt Inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the Type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res 25: 200-210.
19. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314.
20. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Pena J, Johnson RL, Izpisua Belmonte JC, Tabin CJ. 1998. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science (New York, NY) 280: 1274-1277.
21. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. 2004. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 279: 50773-50780.
22. Krause C, Korchynskyi O, de Rooij K, Weidauer SE, de Gorter DJ, van Bezooijen RL, Hatsell S, Economides AN, Mueller TD, Lowik CW, ten Dijke P. 2010. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem 285: 41614-41626.
23. Krishnan V, Bryant HU, Macdougald OA. 2006. Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209.
24. Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. 2000. The Wnt/Ca2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet 16: 279-283.
25. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM. 1999. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73: 114-125.
26. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM. 2003a. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278: 34387-34394.
27. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. 2003b. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Rese Commun 309: 689-694.
28. Lee MH, Kim YJ, Yoon WJ, Kim JI, Kim BG, Hwang YS, Wozney JM, Chi XZ, Bae SC, Choi KY, Cho JY, Choi JY, Ryoo HM. 2005. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280: 35579-35587.
29. Leucht P, Kim JB, Helms JA. 2008. Beta-catenin-dependent Wnt signaling in mandibular bone regeneration. J Bone Joint Surg 90: 3-8.
30. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280: 19883-19887.
31. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N. 2004. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 92: 458-471.
32. Mao J, Wang J, Liu B, Pan W, Farr GH III, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D. 2001. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809.
33. Martin ADV, Fisher LW, Hedge AM, Rowe PS. 2007. Reduced kidney-stone formation and altered renal phosphate-homeostasis in mice over-expressing murine-MEPE. J Bone Miner Res 2: F1118.
34. Miller JR, Hocking AM, Brown JD, Moon RT. 1999. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18: 7860-7872.
35. Mlodzik M. 2002. Planar cell polarization: Do the same mechanisms regulate Drosophila tissue polarity and vertebrate gastrulation? Trends Genet 18: 564-571.
36. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. 1999. Stimulation of bone formation in vitro and in rodents by statins. Science (New York, NY) 286: 1946-1949.
37. Nagel DE, Khosla S, Sanyal A, Rosen DM, Kumagai Y, Riggs BL. 2004. A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors. J Cell Biochem 93: 1107-1114.
38. Nakashima A, Katagiri T, Tamura M. 2005. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem 280: 37660-37668.
39. Nusse R. 2003. Wnts and Hedgehogs: Lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development (Cambridge, England) 130: 5297-5305.
40. Nusse R, Brown A, Papkoff J, Scambler P, Shackleford G, McMahon A, Moon R, Varmus H. 1991. A new nomenclature for int-1 and related genes: The Wnt gene family. Cell 64: 231.
41. Ogbureke KU, Fisher LW. 2005. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int 68: 155-166.
42. Qiang YW, Rudikoff S. 2004. Wnt signaling in B and T lymphocytes. Front Biosci 9: 1000-1010.
43. Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J, Jr., Rudikoff S. 2005. Wnts induce migration and invasion of myeloma plasma cells. Blood 106: 1786-1793.
44. Qiang YW, Hu B, Chen Y, Zhong Y, Shi B, Barlogie B, Shaughnessy JD, Jr. 2009. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling. Blood 113: 4319-4330.
45. Qin C, Baba O, Butler WT. 2004. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15: 126-136.
46. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. 2005. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112: I229-234.
47. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18: 1842-1853.
48. Rowe PS. 2004. The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med 15: 264-281.
49. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL. 2000. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67: 54-68.
50. Ryoo HM, Lee MH, Kim YJ. 2006. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366: 51-57.
51. Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM. 1999. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science (New York, NY) 283: 2089-2091.
52. Sprowson AP, McCaskie AW, Birch MA. 2008. ASARM-truncated MEPE and AC-100 enhance osteogenesis by promoting osteoprogenitor adhesion. J Orthop Res 26: 1256-1262.
53. Winkler DG, Sutherland MS, Ojala E, Turcott E, Geoghegan JC, Shpektor D, Skonier JE, Yu C, Latham JA. 2005. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J Biol Chem 280: 2498-2502.
54. Yoon WJ, Cho YD, Cho KH, Woo KM, Baek JH, Cho JY, Kim GS, Ryoo HM. 2008. The Boston-type craniosynostosis mutation MSX2 (P148H) results in enhanced susceptibility of MSX2 to ubiquitin-dependent degradation. J Biol Chem 283: 32751-32761.
55. Zhang M, Yan Y, Lim YB, Tang D, Xie R, Chen A, Tai P, Harris SE, Xing L, Qin YX, Chen D. 2009. BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J Cell Biochem 108: 896-905.